Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2758006)

Published in J Biol Chem on July 06, 2009

Authors

Jeanne A Hardy1, James A Wells

Author Affiliations

1: Sunesis Pharmaceuticals, South San Francisco, California 94080, USA.

Articles citing this

Phosphorylation regulates assembly of the caspase-6 substrate-binding groove. Structure (2012) 1.20

New approaches for dissecting protease functions to improve probe development and drug discovery. Nat Struct Mol Biol (2012) 1.11

Substrate-induced conformational changes occur in all cleaved forms of caspase-6. J Mol Biol (2010) 1.10

Allostery is an intrinsic property of the protease domain of DegS: implications for enzyme function and evolution. J Biol Chem (2010) 1.00

Zinc-mediated allosteric inhibition of caspase-6. J Biol Chem (2012) 0.92

Allosteric regulation of protease activity by small molecules. Mol Biosyst (2010) 0.92

Evolution of oligomeric state through geometric coupling of protein interfaces. Proc Natl Acad Sci U S A (2012) 0.92

Impact of mutations on the allosteric conformational equilibrium. J Mol Biol (2012) 0.91

A class of allosteric caspase inhibitors identified by high-throughput screening. Mol Cell (2012) 0.85

Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis. Nat Protoc (2010) 0.85

Allosteric modulation of caspase 3 through mutagenesis. Biosci Rep (2012) 0.84

A bifunctional allosteric site in the dimer interface of procaspase-3. Biophys Chem (2011) 0.83

A designed redox-controlled caspase. Protein Sci (2011) 0.82

A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases. Methods Enzymol (2014) 0.79

Enhanced interrogation: emerging strategies for cell signaling inhibition. Nat Struct Mol Biol (2010) 0.78

Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms. Structure (2016) 0.76

Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery. Curr Top Med Chem (2016) 0.75

Articles cited by this

A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97

Serine protease mechanism and specificity. Chem Rev (2002) 5.46

Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell (2002) 5.31

The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J (2004) 4.85

Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell (2008) 4.00

Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell (2008) 3.64

On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun (1968) 3.10

Structural basis of caspase-7 inhibition by XIAP. Cell (2001) 2.99

The CASBAH: a searchable database of caspase substrates. Cell Death Differ (2007) 2.89

Discovery of an allosteric site in the caspases. Proc Natl Acad Sci U S A (2004) 2.51

Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell (2001) 2.39

The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol (1996) 2.17

Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14

A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A (2006) 2.12

IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol (1991) 1.98

Purification and catalytic properties of human caspase family members. Cell Death Differ (1999) 1.96

Caspases: keys in the ignition of cell death. Chem Rev (2002) 1.91

The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol (2000) 1.82

Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell (2006) 1.43

Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci U S A (2009) 1.40

An allosteric circuit in caspase-1. J Mol Biol (2008) 1.38

Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding. Structure (2004) 1.24

Engineered hybrid dimers: tracking the activation pathway of caspase-7. Mol Cell (2006) 1.14

Malonate-assisted purification of human caspases. Protein Expr Purif (2005) 1.12

Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J (2007) 1.09

Structural and functional analysis of caspase active sites. Biochemistry (2003) 0.93

Drug discovery opportunities from apoptosis research. Curr Opin Biotechnol (2000) 0.92

Molecular regulation of inflammation and cell death. Cytokine (2008) 0.91

Mechanism of action of cysteine proteinases: oxyanion binding site is not essential in the hydrolysis of specific substrates. Biochemistry (1985) 0.91

Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies. Drug Discov Today (2001) 0.88

Articles by these authors

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov (2004) 7.84

Repairing research integrity. Nature (2008) 5.91

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature (2013) 4.43

Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell (2008) 4.00

Discovery of an allosteric site in the caspases. Proc Natl Acad Sci U S A (2004) 2.51

Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males. Cell (2013) 2.41

Tethering: fragment-based drug discovery. Annu Rev Biophys Biomol Struct (2004) 2.37

Searching for new allosteric sites in enzymes. Curr Opin Struct Biol (2004) 2.31

A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A (2006) 2.12

Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell (2010) 1.85

Caspase substrates and cellular remodeling. Annu Rev Biochem (2011) 1.79

Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A (2003) 1.78

Small-molecule activators of a proenzyme. Science (2009) 1.72

Nature-inspired design of motif-specific antibody scaffolds. Nat Biotechnol (2013) 1.68

Inflammatory stimuli regulate caspase substrate profiles. Mol Cell Proteomics (2010) 1.57

Hot-spot mimicry of a cytokine receptor by a small molecule. Proc Natl Acad Sci U S A (2006) 1.47

Turning enzymes ON with small molecules. Nat Chem Biol (2010) 1.47

Mechanistic diversity of cytokine receptor signaling across cell membranes. Sci STKE (2004) 1.42

Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci U S A (2009) 1.40

An allosteric circuit in caspase-1. J Mol Biol (2008) 1.38

Global kinetic analysis of proteolysis via quantitative targeted proteomics. Proc Natl Acad Sci U S A (2012) 1.36

The DegraBase: a database of proteolysis in healthy and apoptotic human cells. Mol Cell Proteomics (2012) 1.34

Turning a protein kinase on or off from a single allosteric site via disulfide trapping. Proc Natl Acad Sci U S A (2011) 1.33

Sampling the N-terminal proteome of human blood. Proc Natl Acad Sci U S A (2010) 1.28

Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. Proc Natl Acad Sci U S A (2005) 1.23

Global cellular response to chemotherapy-induced apoptosis. Elife (2013) 1.19

Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation. J Am Chem Soc (2011) 1.14

Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci U S A (2003) 1.13

Malonate-assisted purification of human caspases. Protein Expr Purif (2005) 1.12

Methods for the proteomic identification of protease substrates. Curr Opin Chem Biol (2009) 1.07

Prediction of protease substrates using sequence and structure features. Bioinformatics (2010) 1.04

Potent small-molecule binding to a dynamic hot spot on IL-2. J Am Chem Soc (2003) 1.02

Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis. Proc Natl Acad Sci U S A (2012) 1.02

Ordering a dynamic protein via a small-molecule stabilizer. J Am Chem Soc (2013) 0.97

Fibrils colocalize caspase-3 with procaspase-3 to foster maturation. J Biol Chem (2012) 0.97

Substrates of IAP ubiquitin ligases identified with a designed orthogonal E3 ligase, the NEDDylator. Mol Cell (2012) 0.97

Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor. J Biol Chem (2004) 0.96

Molecules that modulate Apaf-1 activity. Med Res Rev (2010) 0.92

Tags for labeling protein N-termini with subtiligase for proteomics. Bioorg Med Chem Lett (2008) 0.91

Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation. Proc Natl Acad Sci U S A (2013) 0.91

Apo cytochrome c inhibits caspases by preventing apoptosome formation. Biochem Biophys Res Commun (2004) 0.89

Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3. J Biol Chem (2013) 0.82

Structural and enzymatic insights into caspase-2 protein substrate recognition and catalysis. J Biol Chem (2011) 0.81

Identification of specific tethered inhibitors for caspase-5. Chem Biol Drug Des (2011) 0.76

Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition. ACS Chem Biol (2016) 0.76

Computational approach to site-directed ligand discovery. Proteins (2007) 0.76

Warren L. DeLano 21 June 1972-3 November 2009. Nat Struct Mol Biol (2009) 0.75

Structure-Activity Relationship and Molecular Mechanics Reveal the Importance of Ring Entropy in the Biosynthesis and Activity of a Natural Product. J Am Chem Soc (2017) 0.75

Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike. bioRxiv (2020) 0.75

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. medRxiv (2020) 0.75

Regulated cell death part A: apoptotic mechanisms. Preface. Methods Enzymol (2014) 0.75

Methods in Enzymology. Regulated cell death part B--necroptotic, autophagic and other non-apoptotic mechanisms. Preface. Methods Enzymol (2014) 0.75

Next generation therapeutics. Curr Opin Chem Biol (2013) 0.75